Azenta Inc

Healthcare · Medical Instruments & Supplies

34.10$ -0.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Azenta Inc (AZTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 2,060 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AZTA
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	65	150	141	177	513	704	657	493	671	624	993	1,015	664	413	518	637	742	737	778	760	686	767	1,096	1,517	1,559	1,820	3,716	2,886	2,100	2,060
Current Assets	46	127	118	138	395	383	334	270	461	466	433	480	339	221	327	321	347	330	374	373	299	352	565	648	649	777	2,459	1,419	833	708
Cash	2.1	72	68	66	131	160	125	125	193	202	116	168	110	60	60	59	55	83	94	81	85	102	198	302	296	227	658	679	311	280
Cash & Short-Term Investments	2.1	72	68	66	219	204	151	129	255	324	184	248	143	88	109	125	140	129	162	151	85	102	244	336	296	228	1,570	1,018	462	341
Receivables	24	28	21	33	93	94	89	69	124	78	113	106	76	38	92	77	79	77	80	86	106	93	125	166	95	120	164	157	173	189
Inventory	18	23	20	29	57	49	78	53	72	48	100	105	106	85	116	108	103	98	94	101	93	106	97	99	115	60	86	128	115	75
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	60	101	112	180	154	272	–	–
Goodwill	–	–	–	–	–	–	104	69	62	62	351	319	120	48	48	85	88	122	110	121	202	234	256	489	502	469	514	784	691	702
Intangible Assets	–	–	–	14	60	101	119	80	6.9	3.8	94	77	58	14	11	44	39	60	60	55	82	84	100	251	218	187	178	294	248	102
Total Liabilities	14	16	19	34	98	279	349	330	357	313	193	155	121	94	129	118	93	104	135	128	132	159	378	378	346	494	353	351	331	331
Current Liabilities	13	14	18	32	92	95	157	135	167	125	180	143	103	70	108	96	81	93	114	114	120	147	165	273	211	345	231	211	205	238
Short-Term Debt	1.4	0.6	0.5	6.4	17	18	0.0	0.1	0.0	0.0	0.0	–	–	2.7	1.0	4.0	1.7	1.1	0.9	6.1	7.6	11	2.0	0.8	0.8	148	7.0	10	11	7.8
Accounts Payable	8.1	9.9	3.3	12	21	19	30	27	45	31	69	58	37	26	66	40	29	35	34	45	41	49	45	59	26	42	39	36	44	38
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	194	50	50	50	–	–	–	–
Shareholders' Equity	51	134	122	142	414	424	308	162	313	310	799	860	542	319	389	518	649	632	643	632	554	608	718	1,139	1,214	1,325	3,363	2,535	1,769	1,727
Retained Earnings	65	17	-6.5	-26	-16	-45	-765	-951	-933	-943	-980	-829	-1,065	-1,293	-1,234	-1,111	-993	-1,016	-1,007	-1,020	-1,117	-1,082	-994	-586	-551	-470	1,655	1,641	1,477	1,420
Shares Outstanding	8.6	7.9	10	11	17	18	26	37	43	45	73	74	65	63	64	65	66	66	68	69	69	70	71	72	74	74	75	66	53	46

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings